Literature DB >> 13712355

Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy.

A HAUT, W S ABBOTT, M M WINTROBE, G E CARTWRIGHT.   

Abstract

Entities:  

Keywords:  BUSULFAN/therapy; LEUKEMIA, MYELOCYTIC/therapy

Mesh：

Substances：

Year:  1961        PMID： 13712355

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  IN VIVO EFFECTS OF METHYLENE DIMETHANESULPHONATE ON PROLIFERATING CELL SYSTEMS.

Authors:  B W FOX; H JACKSON
Journal:  Br J Pharmacol Chemother       Date:  1965-02

2.  [Long-term chemotherapy of chronic myeloid leukemia with Myleran and C69].

Authors:  H EHRHART
Journal:  Klin Wochenschr       Date:  1962-06-15

3.  Chemotherapy of malignant disease: a review of theory and practice.

Authors:  G D HART
Journal:  Can Med Assoc J       Date:  1962-03-31       Impact factor: 8.262

4.  Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha.

Authors:  R Hehlmann; B Anger; D Messerer; R Zankovich; L Bergmann; H J Kolb; P Meyer; U Essers; U Queisser; H Vaupel
Journal:  Blut       Date:  1988-02

5.  Chronic granulocytic leukaemia: comparison of radiotherapy and busulphan therapy. Report of the Medical Research Council's working party for therapeutic trials in leukaemia.

Authors: 
Journal:  Br Med J       Date:  1968-01-27

6.  Syndrome resembling Addison's disease following prolonged treatment with busulphan.

Authors:  B P Harrold
Journal:  Br Med J       Date:  1966-02-19

7.  DNA repair mechanisms in cancer development and therapy.

Authors:  Alessandro Torgovnick; Björn Schumacher
Journal:  Front Genet       Date:  2015-04-23       Impact factor: 4.599

8.  Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model.

Authors:  Nadim Mahmud; Amit Khanal; Simona Taioli; Emre Koca; Sujata Gaitonde; Benjamin Petro; Karen Sweiss; Lisa Halliday; Xinhe Wang; Pritesh Patel; Damiano Rondelli
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.